Heterozygous Familial Hypercholesterolemia Drug Market Worldwide Industry Analysis, Future Demand and Forecast till 2029

Heterozygous familial hypercholesterolemia drug market is anticipated to grow at a significant CAGR during the forecast period. Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder. It causes high cholesterol levels that lead to heart disease, heart attack, or stroke. Additionally, HeFH is one form of Familial Hypercholesterolemia (FH). The major factor driving the demand for the heterozygous familial hypercholesterolemia drug is the increasing prevalence of familial hypercholesterolemia across the globe. 

According to Medline Plus, familial hypercholesterolemia affects an estimated 1 in 200 to 1 in 250 people in most countries. Additionally, it is the most common inherited condition affecting the heart and blood vessels. Furthermore, the condition occurs more frequently in certain populations that include Afrikaners in South Africa, Lebanese, and Tunisians. Hence, the increasing prevalence of familial hypercholesterolemia is driving the demand for heterozygous familial hypercholesterolemia drugs for treatment which in turn is driving the growth of the market.

 

Some major players in the market include Sanofi SA, Amgen Inc., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Amgen announced the approval of  Repatha (evolocumab) from the US Food and Drug Administration (FDA). It is used as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering therapies for the treatment of heterozygous familial hypercholesterolemia (HeFH) in pediatric patients aged 10 years and older.

To Request a Sample of our Report on Heterozygous Familial Hypercholesterolemia Drug Market:  https://www.omrglobal.com/request-sample/heterozygous-familial-hypercholesterolemia-drug-market

Market Coverage

The market number available for - 2021-2029
Base year- 2022
Forecast period- 2023-2029

Segment Covered- 

By Product Type
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Sanofi SA, Amgen Inc., and Novartis International AG, among others. 

Heterozygous Familial Hypercholesterolemia Drug Market Report by Segment

By Type

Gemcabene Calcium
MGL-3196
ST-103
Others

By Application 

Hospital
Medical Center
Clinics
Others

A full Report of Heterozygous Familial Hypercholesterolemia Drug Market is Available @ https://www.omrglobal.com/industry-reports/heterozygous-familial-hypercholesterolemia-drug-market

 Heterozygous Familial Hypercholesterolemia Drug Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.asiatimeskorea.com/news/%ec%9e%a5%eb%87%8c-%ec%8b%9c%ec%9e%a5-%ea%b0%80%ec%b9%98%eb%8a%94-2029%eb%85%84%ea%b9%8c%ec%a7%80-%ed%99%95%ec%9e%a5%eb%90%a0-%ea%b2%83%ec%9c%bc%eb%a1%9c-%ec%98%88%ec%83%81%eb%90%a9%eb%8b%88%eb%8b%a4/443622/
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/%ec%9d%bc%ed%9a%8c%ec%9a%a9-%ed%8c%90-%ec%8b%9c%ec%9e%a5%ec%9d%80-2029%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b8%89%ec%86%8d%ed%95%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%bc-%ea%b2%83%ec%9e%85%eb%8b%88%eb%8b%a4/88595/
https://monblogapple.com/2023/04/24/la-valeur-marchande-des-supplements-a-base-de-plantes-devrait-augmenter-dici-2029/
https://revistaeconomiasocial.com/2023/04/24/el-mercado-de-envases-de-alimentos-sera-testigo-de-una-solida-expansion-para-2029/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.